© 2020 MJH Life Sciences and Contagion Live. All rights reserved.
© 2020 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 26, 2020
A glimpse into FDA advisor perspective just weeks before EUAs are anticipated to be sent.
October 25, 2020
Why it may be more prudent for prescribing clinicians to assume viral, rather than bacterial, infection while awaiting test results in presenting pediatric cases.
The presenting IDWeek author discusses the implication of promising phase 3 data for a new HBV vaccine.
New data may evidence oral care as a therapeutic measure to reduce bacterial and viral spread.